» Articles » PMID: 38184643

Minimally Sufficient Experimental Design Using Identifiability Analysis

Overview
Specialty Biology
Date 2024 Jan 6
PMID 38184643
Authors
Affiliations
Soon will be listed here.
Abstract

Mathematical models are increasingly being developed and calibrated in tandem with data collection, empowering scientists to intervene in real time based on quantitative model predictions. Well-designed experiments can help augment the predictive power of a mathematical model but the question of when to collect data to maximize its utility for a model is non-trivial. Here we define data as model-informative if it results in a unique parametrization, assessed through the lens of practical identifiability. The framework we propose identifies an optimal experimental design (how much data to collect and when to collect it) that ensures parameter identifiability (permitting confidence in model predictions), while minimizing experimental time and costs. We demonstrate the power of the method by applying it to a modified version of a classic site-of-action pharmacokinetic/pharmacodynamic model that describes distribution of a drug into the tumor microenvironment (TME), where its efficacy is dependent on the level of target occupancy in the TME. In this context, we identify a minimal set of time points when data needs to be collected that robustly ensures practical identifiability of model parameters. The proposed methodology can be applied broadly to any mathematical model, allowing for the identification of a minimally sufficient experimental design that collects the most informative data.

Citing Articles

A Systematic Computational Framework for Practical Identifiability Analysis in Mathematical Models Arising from Biology.

Wang S, Hao W ArXiv. 2025; .

PMID: 39801621 PMC: 11722522.


Mitigating non-genetic resistance to checkpoint inhibition based on multiple states of immune exhaustion.

Kareva I, Gevertz J NPJ Syst Biol Appl. 2024; 10(1):14.

PMID: 38336968 PMC: 10858190. DOI: 10.1038/s41540-024-00336-6.

References
1.
Eisenberg M, Jain H . A confidence building exercise in data and identifiability: Modeling cancer chemotherapy as a case study. J Theor Biol. 2017; 431:63-78. PMC: 6007023. DOI: 10.1016/j.jtbi.2017.07.018. View

2.
Kreutz C, Timmer J . Systems biology: experimental design. FEBS J. 2009; 276(4):923-42. DOI: 10.1111/j.1742-4658.2008.06843.x. View

3.
Rajakaruna H, Ganusov V . Mathematical Modeling to Guide Experimental Design: T Cell Clustering as a Case Study. Bull Math Biol. 2022; 84(10):103. PMC: 9548402. DOI: 10.1007/s11538-022-01063-x. View

4.
Cardenas S, Reznik C, Ranaweera R, Song F, Chung C, Fertig E . Model-informed experimental design recommendations for distinguishing intrinsic and acquired targeted therapeutic resistance in head and neck cancer. NPJ Syst Biol Appl. 2022; 8(1):32. PMC: 9458753. DOI: 10.1038/s41540-022-00244-7. View

5.
Zhang J, Gallaher J, Cunningham J, Choi J, Ionescu F, Chatwal M . A Phase 1b Adaptive Androgen Deprivation Therapy Trial in Metastatic Castration Sensitive Prostate Cancer. Cancers (Basel). 2022; 14(21). PMC: 9656891. DOI: 10.3390/cancers14215225. View